BTWM
GILD icon

Baker Tilly Wealth Management’s Gilead Sciences GILD Stock Holding History

Baker Tilly Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,712
Closed -$378K – 297
2026
Q1 		$378K Sell
2,712
-140
-5% -$19.6K 0.09% 185
2025
Q4 		$350K Buy
2,852
+338
+13% +$41.1K 0.09% 200
2025
Q3 		$279K Buy
2,514
+106
+4% +$12K 0.06% 228
2025
Q2 		$267K Buy
2,408
+108
+5% +$11.5K 0.1% 200
2025
Q1 		$258K Sell
2,300
-3,273
-59% -$338K 0.1% 201
2024
Q4 		$515K Sell
5,573
-735
-12% -$66.2K 0.2% 115
2024
Q3 		$529K Sell
6,308
-313
-5% -$23.9K 0.23% 109
2024
Q2 		$454K Sell
6,621
-10,845
-62% -$724K 0.19% 133
2024
Q1 		$1.28M Sell
17,466
-567
-3% -$43.6K 0.23% 99
2023
Q4 		$1.46M Buy
18,033
+8,898
+97% +$692K 0.24% 96
2023
Q3 		$685K Buy
9,135
+3,441
+60% +$265K 0.11% 184
2023
Q2 		$439K Buy
5,694
+128
+2% +$10.2K 0.05% 371
2023
Q1 		$462K Buy
5,566
+150
+3% +$12.4K 0.05% 357
2022
Q4 		$465K Sell
5,416
-2,175
-29% -$172K 0.06% 343
2022
Q3 		$468K Sell
7,591
-38
-0.5% -$2.4K 0.06% 306
2022
Q2 		$472K Buy
7,629
+208
+3% +$12.9K 0.06% 322
2022
Q1 		$441K Sell
7,421
-916
-11% -$58.6K 0.05% 365
2021
Q4 		$605K Buy
8,337
+1,620
+24% +$112K 0.06% 317
2021
Q3 		$469K Buy
6,717
+782
+13% +$54.9K 0.06% 327
2021
Q2 		$409K Buy
5,935
+899
+18% +$60K 0.07% 326
2021
Q1 		$325K Buy
5,036
+1,454
+41% +$93.8K 0.07% 338
2020
Q4 		$209K Buy
+3,582
New +$216K 0.06% 314

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Baker Tilly Wealth Management's GILD Position: Q2 2026 in Review

Baker Tilly Wealth Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 2,712 shares — an estimated $378K sold.

Baker Tilly Wealth Management first reported a position in GILD in Q4 2020 and held it in 22 quarters. The position peaked at $1.46M in Q4 2023. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Baker Tilly Wealth Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Baker Tilly Wealth Management sold 2,712 Gilead Sciences shares in Q2 2026, an estimated $378K.
  • Baker Tilly Wealth Management first reported a position in Gilead Sciences in Q4 2020 and held it in 22 quarters.
  • Baker Tilly Wealth Management's Gilead Sciences position peaked at $1.46M in Q4 2023.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Baker Tilly Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.